Evaluation of Infection Parameters in the Production of Replication‐Defective HSV‐1 Viral Vectors
- 1 January 2002
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 18 (3) , 476-482
- https://doi.org/10.1021/bp010176k
Abstract
Herpes simplex virus type-1 (HSV-1) is a neurotrophic human pathogen that establishes life-long latency in the nervous system. Our laboratory has extensively engineered this virus to retain the ability to persist in neurons without expression of lytic genes or disease phenotype. Highly defective, replication-incompetent HSV mutants are thus potentially ideal for transfer of therapeutic transgenes to human nerves where long-term therapy of nervous system disease may be provided. A prerequisite for using recombinant HSV vectors for therapeutic gene delivery to humans is the development of methods for large-scale manufacture of HSV vectors. Here we report studies to identify infection parameters that result in high-yield production of immediate early gene deletion mutant HSV vectors in complementing cells that supply the deleted essential viral functions in trans. Virus yield was correlated with various culture media conditions that included pH, glucose metabolism, and serum levels. The results demonstrated that systematic media exchange to remove lactate derived from high-level glucose consumption, maintenance of tissue culture pH at 6.8, and the use of 5% fetal bovine serum gave the highest yield of infectious virus. The data indicate that these are important parameters to consider for high-yield, large-scale virus production.Keywords
This publication has 20 references indexed in Scilit:
- Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant gliomaGene Therapy, 2000
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsGene Therapy, 1998
- Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applicationsGene Therapy, 1998
- Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cellsBiotechnology & Bioengineering, 1998
- Rapid method for construction of recombinant HSV gene transfer vectorsGene Therapy, 1997
- Replication-defective herpes simplex virus vectors for gene transfer in vivo.Proceedings of the National Academy of Sciences, 1996
- Optimization of environmental factors for the production and handling of recombinant retrovirusApplied Microbiology and Biotechnology, 1996
- Mild Acidic pH Inhibition of the Major Pathway of Herpes Simplex Virus Entry into HEp-2 CellsJournal of General Virology, 1989
- Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4.Molecular and Cellular Biology, 1985